Good day to you.
Please help me regarding below issue.
“Is there any rule of skipping validation of mid strength batch while performed in upper & lower strength. for example, Atorvastatin calcium 10 mg tablet, 20 mg tablet, 40 mg tablet are present. Method validation of 10 mg & 40 mg were performed , 20 mg was not done. is it complied by any regulation/rules?”
Any reference will be helpful.
waiting for your valuable feedback.